Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
Predictive models of immune protection from COVID-19 are urgently needed to identify
correlates of protection to assist in the future deployment of vaccines. To address this, we …
correlates of protection to assist in the future deployment of vaccines. To address this, we …
[HTML][HTML] Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection
A proportion of patients surviving acute coronavirus disease 2019 (COVID-19) infection develop
post-acute COVID syndrome (long COVID (LC)) lasting longer than 12 weeks. Here, we …
post-acute COVID syndrome (long COVID (LC)) lasting longer than 12 weeks. Here, we …
Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis
Background Several SARS-CoV-2 variants of concern have been identified that partly escape
serum neutralisation elicited by current vaccines. Studies have also shown that vaccines …
serum neutralisation elicited by current vaccines. Studies have also shown that vaccines …
Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies
Antibody-based drugs and vaccines against severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) are being expedited through preclinical and clinical development. Data …
2 (SARS-CoV-2) are being expedited through preclinical and clinical development. Data …
Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19
…, HG Kelly, K Wragg, R Esterbauer, HE Kent… - Nature medicine, 2020 - nature.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has
dramatically expedited global vaccine development efforts 1 , 2 – 3 , most targeting the viral ‘spike’ …
dramatically expedited global vaccine development efforts 1 , 2 – 3 , most targeting the viral ‘spike’ …
Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19
The durability of infection-induced SARS-CoV-2 immunity has major implications for reinfection
and vaccine development. Here, we show a comprehensive profile of antibody, B cell …
and vaccine development. Here, we show a comprehensive profile of antibody, B cell …
Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection
Immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is
central to long-term control of the current pandemic. Despite our rapidly advancing knowledge …
central to long-term control of the current pandemic. Despite our rapidly advancing knowledge …
Long-lived epithelial immunity by tissue-resident memory T (TRM) cells in the absence of persisting local antigen presentation
…, AT Stock, JZ Ma, CM Jones, SJ Kent… - Proceedings of the …, 2012 - National Acad Sciences
Although circulating memory T cells provide enhanced protection against pathogen challenge,
they often fail to do so if infection is localized to peripheral or extralymphoid compartments…
they often fail to do so if infection is localized to peripheral or extralymphoid compartments…
Minimum information reporting in bio–nano experimental literature
M Faria, M Björnmalm, KJ Thurecht, SJ Kent… - Nature …, 2018 - nature.com
Studying the interactions between nanoengineered materials and biological systems plays
a vital role in the development of biological applications of nanotechnology and the …
a vital role in the development of biological applications of nanotechnology and the …
Anti-PEG antibodies boosted in humans by SARS-CoV-2 lipid nanoparticle mRNA vaccine
Humans commonly have low level antibodies to poly(ethylene) glycol (PEG) due to
environmental exposure. Lipid nanoparticle (LNP) mRNA vaccines for SARS-CoV-2 contain small …
environmental exposure. Lipid nanoparticle (LNP) mRNA vaccines for SARS-CoV-2 contain small …
